Sakamaki H | Tokyo Metropolitan Komagome Hospital Tokyo Jpn
スポンサーリンク
概要
関連著者
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
Kami Masahiro
Jr東京総合病院 血液内科
-
OKA Yoshihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TSUBOI Akihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
KAWAKAMI Manabu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
NISHIDA Sumiyuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
HOSEN Naoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
Soma Toshihiro
大阪大学 医学系研究科
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
KAWASE Ichiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
OHNO Ryuzo
Aichi Cancer Center
-
Tobinai Kensei
東海大学 医学部
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MASUDA Tomoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
AOZASA Katsuyuki
Department of Pathology, Osaka University Graduate School of Medicine
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
IKEGAME Kazuhiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
KAKIHANA Kazuhiko
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
谷脇 雅文
高知工科大学工学部
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
MUKUBO Masaaki
Yodogawa Christian Hospital
-
MURAKAMI Masaki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
INOUE Yoriko
Nagasaki CML Study Group
-
JINNAI Itsuro
Nagasaki CML Study Group
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
Kunitomi Akane
Department of Hematology, Meitetsu Hospital
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
永井 正
自治医科大学内科学講座血液学部門
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Yokota Asumi
大阪大学 医系研究 病態生体情報学
-
Yokota Asumi
Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine
-
Miyamoto Toshihiro
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学
-
FUJIOKA Tatsuya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TANIGUCHI Yuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
ASADA Momotaro
Department of Clinical Laboratory Science, Osaka University Medical School
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Ogawa Daisuke
Nagasaki Cml Study Group
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
SAKAI Mari
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MATSUO Emi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIUCHI Yukiyoshi
Nagasaki CML Study Group
-
FUKUSHIMA Takuya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMAIZUMI Yoshitaka
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUSHIMA Hideki
Nagasaki CML Study Group
-
TAKASAKI Yumi
Nagasaki CML Study Group
-
NAGAI Kazuhiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUTSUMI Chizuko
Nagasaki CML Study Group
-
SAWAYAMA Yasushi
Nagasaki CML Study Group
-
YAMASAKI Reishi
Nagasaki CML Study Group
-
KAWAGUCHI Yasuhisa
Nagasaki CML Study Group
-
IKEDA Shuichi
Nagasaki CML Study Group
-
YOSHIDA Shinichiro
Nagasaki CML Study Group
-
ONIMARU Yasuyuki
Nagasaki CML Study Group
-
ATOGAMI Sunao
Nagasaki CML Study Group
-
JOH Tatsuro
Nagasaki CML Study Group
-
YAMAMURA Masaomi
Nagasaki CML Study Group
-
MATSUO Yuji
Nagasaki CML Study Group
-
SODA Hisashi
Nagasaki CML Study Group
-
NONAKA Hiroaki
Nagasaki CML Study Group
-
YOSHIMINE Toshiki
Department of Neurosurgery, Osaka University Medical School
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
YAMAMOTO Masahide
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
TADOKORO Kenichi
Development of Clinical Genomics, BML
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
KAMIMURA Tomohiko
Department of Hematology, Harasanshin General Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Ogata Kentaro
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Takamatsu Yasushi
First Department of Internal Medicine, Fukuoka University
-
Tamura Kazuo
First Department of Internal Medicine, Fukuoka University
-
Hara Shuuji
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Hayashi Mayuko
Department of Hematology, Meitetsu Hospital
-
清水 隆之
慶應義塾大学医学部血液内科
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
桜井 幹己
大阪大学病理部
-
SANAKA Masaki
Department of Internal Medicine, Teikyo University School of Medicine
-
小嶋 哲人
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
小嶋 哲人
名古屋大学医学部第一内科
-
小嶋 哲人
名古屋大学 保健
-
桜井 幹己
大阪市立大学医学部第2病理
-
MATSUSHITA Tadashi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Adachi Yoshihiro
Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
Kawano Kiyoshi
Department Of Clinical Pathology Osaka Rosai Hospital
-
Kawano Kiyoshi
大阪大学 大学院 医学系研究科 保健学専攻 機能診断科学 講座
-
Kawano Kiyoshi
Department Of Pathology Osaka Rosai
-
OGAWA Daisuke
Department of Medicine and Clinical Science (Internal Medicine III), Okayama University Graduate Sch
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
FUJIWARA TOHRU
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
MONDEN Morito
Department of Surgery and Clinical Oncology, Osaka University Graduate School of Medicine
-
MORITA Satoshi
Department of Young Leaders' Program in Health Care Administration, Nagoya University Graduate Schoo
-
SAKAMOTO Junichi
Department of Young Leaders' Program in Health Care Administration, Nagoya University Graduate Schoo
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
-
INOHARA HIDENORI
Department of Radiation Biology, Faculty of Medicine, Osaka University
-
Yokoyama Reiko
Pharmacy Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
SAITO Hidehiko
Nagoya Central Hospital
-
KOJIMA Tetsuhito
Department of Medical Technology, Nagoya University School of Health Sciences
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
TAMAKI Hiroya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
YAMAGAMI Tamotsu
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
KIM Eui
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MISHIMA Machiko
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SOMA Toshihiro
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
OSUMI Kazuoki
Otsuka Pharmaceutical Co. Ltd.
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
NAKAGOME KAZUYUKI
Department of Psychiatry, Showa University School of Medicine
-
SETO Masao
Laboratories of Chemotherapy and Immunology, Aichi Cancer Research Institute
-
YAMAMOTO HIROFUMI
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
TAJIMA Tsuyoshi
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
MORI Shin-ichiro
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
Naka Yoshifumi
大阪市立大学 医学研究科整形外科学
-
TSUCHIYA Takeshi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOMODA Minori
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
HORIO Kensuke
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIWAKI Yuji
Nagasaki CML Study Group
-
TOMINAGA Shinya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
ITONAGA Hidehiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOIDA Satoshi
Nagasaki CML Study Group
著作論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Primary Sclerosing Cholangitis Complicated with Idiopathic Thrombocytopenic Purpura
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Utility and Safety of Hickman Catheters for Venous Access after Bone Marrow Transplantation
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Endoscopic Findings of Acute Intestinal Graft-versus-host Disease after Bone Marrow Transplantation
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Pneumatosis coli after Thalidomide Treatment
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
- WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
- The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
- Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
- Bone marrow transplantation in subjects with mental disorders
- WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
- Psychological factors and survival after bone marrow transplantation in patients with leukemia
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Recombinant human erythropoetin (rhEPO) administration to marrow donors
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
- Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Osteonecrosis of the humeral head
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation